Role of Enterocyte Enpp2 and Autotaxin in Regulating Lipopolysaccharide Levels, Systemic Inflammation and Atherosclerosis

By sjmartinez • April 15, 2023

Chattopadhyay A, Mukherjee P, Sulaiman D, Wang H, Girjalva V, Dorreh N, Jacobs JP, Delk S, Moolenaar WH, Navab M, Reddy ST, Fogelman AM. Role of Enterocyte Enpp2 and Autotaxin in Regulating Lipopolysaccharide Levels, Systemic Inflammation and Atherosclerosis. J Lipid Res. 2023 Apr 12:100370. doi: 10.1016/j.jlr.2023.100370. Epub ahead of print. PMID: 37059333.

Tags: Apolipoprotein A-I (apoA-I) mimetic peptides, Atherosclerosis, Cardiology/Epi, Digestive Diseases, Lysophosphatidic acid (LPA), Lysophospholipase D, Oxidized phospholipids, Publications, Small intestine, Transgenic tomatoes expressing the apoA-I mimetic peptide 6F (Tg6F)

Clinical phenotypes in acute and chronic infarction explained through human ventricular electromechanical modelling and simulations

Zhou X, Wang ZJ, Camps J, Tomek J, Santiago A, Quintanas A, Vazquez M, Vaseghi M, Rodriguez B. Clinical phenotypes in acute and chronic infarction[...]

Stroke-bleeding risk score pairings within individuals in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry

Jason MJ, Marzec LN, Piccini JP, Shrader P, Pieper KS, Blanco RG, Fonarow GC, Gersh BJ, Ho PM, Hylek E, Kowey PR, Mahaffey KW, Steinberg[...]

When Is Enough Enough? Additional Evidence of the Power of Zero

Budoff MJ. When Is Enough Enough? Additional Evidence of the Power of Zero. Circ Cardiovasc Imaging. 2024 Dec 20:e017714. doi: 10.1161/CIRCIMAGING.124.017714. Epub ahead of print.[...]